Learnings from 30 years of recruiting and enrollment journeys, across thousands of studies in an extensive range of therapeutic areas, are captured in RandIQ, our predictive enrollment solution. RandIQ intelligence, integrated with live patient and site signals, powers StudyMax™, our technology platform to improve forecasting, accurately predict outcomes, surface risk, and enable proactive planning.
%
RandIQ evolves over time, providing increasingly accurate, actionable insights that help sponsors make better decisions before and during enrollment.
Observed enrollment behavior across studies, indications, and markets.
